A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



Jenna Lilyquist, Holly LaDuca, Eric Polley, Brigette Tippin Davis, Hermela Shimelis, Chunling Hu, Steven N Hart, Jill S Dolinsky, Fergus J Couch, David E Goldgar. Gynecol Oncol 2017
Times Cited: 50




List of shared articles



Times cited

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.
Honglin Song, Ed M Dicks, Jonathan Tyrer, Maria Intermaggio, Georgia Chenevix-Trench, David D Bowtell, Nadia Traficante, Aocs Group, James Brenton, Teodora Goranova,[...]. J Med Genet 2021
7

Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Huma Q Rana, Lindsay Kipnis, Kristin Hehir, Angel Cronin, Tim Jaung, Samantha M Stokes, Fatemeh Fekrmandi, Donna Vatnick, Ursula A Matulonis, Judy E Garber,[...]. Gynecol Oncol 2021
1

BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort.
Paula Rofes, Jesús Del Valle, Sara Torres-Esquius, Lídia Feliubadaló, Agostina Stradella, José Marcos Moreno-Cabrera, Adriana López-Doriga, Elisabet Munté, Rafael De Cid, Olga Campos,[...]. Genes (Basel) 2021
0

Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019.
Allison W Kurian, Kevin C Ward, Paul Abrahamse, Irina Bondarenko, Ann S Hamilton, Dennis Deapen, Monica Morrow, Jonathan S Berek, Timothy P Hofer, Steven J Katz. J Clin Oncol 2021
1


RAD51D Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants.
Elena Bueno-Martínez, Lara Sanoguera-Miralles, Alberto Valenzuela-Palomo, Víctor Lorca, Alicia Gómez-Sanz, Sara Carvalho, Jamie Allen, Mar Infante, Pedro Pérez-Segura, Conxi Lázaro,[...]. Cancers (Basel) 2021
0

Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.
Rachel M Hurley, Cordelia D McGehee, Ksenija Nesic, Cristina Correia, Taylor M Weiskittel, Rebecca L Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M Pathoulas, X Wei Meng,[...]. NAR Cancer 2021
0

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
Holly LaDuca, Eric C Polley, Amal Yussuf, Lily Hoang, Stephanie Gutierrez, Steven N Hart, Siddhartha Yadav, Chunling Hu, Jie Na, David E Goldgar,[...]. Genet Med 2020
45

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
Di Shao, Shaomin Cheng, Fengming Guo, Changbin Zhu, Yuying Yuan, Kunling Hu, Zhe Wang, Xuan Meng, Xin Jin, Yun Xiong,[...]. Cancer Sci 2020
6

Genetic cancer predisposition syndromes among older adults.
Yanin Chavarri-Guerra, Thomas P Slavin, Ossian Longoria-Lozano, Jeffrey N Weitzel. J Geriatr Oncol 2020
0

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
41

Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
Shannon K Rush, Elizabeth M Swisher, Rochelle L Garcia, Kathryn P Pennington, Kathy J Agnew, Mark R Kilgore, Barbara M Norquist. Gynecol Oncol 2020
2

Germline PALB2, ATM variants in a patient with breast and ovarian cancer at risk for familial cancer syndrome: Is there a role for risk-reducing salpingo-oophorectomy?
Semiramis L Carbajal-Mamani, Merry J Markham, Joaquín Santolaya-Forgas, Jacqueline C Castagno, Joel Cardenas-Goicoechea. Obstet Gynecol Sci 2020
0

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes.
Deepak N Subramanian, Magnus Zethoven, Simone McInerny, James A Morgan, Simone M Rowley, Jue Er Amanda Lee, Na Li, Kylie L Gorringe, Paul A James, Ian G Campbell. Nat Commun 2020
4

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.
Klara Lhotova, Lenka Stolarova, Petra Zemankova, Michal Vocka, Marketa Janatova, Marianna Borecka, Marta Cerna, Sandra Jelinkova, Jan Kral, Zuzana Volkova,[...]. Cancers (Basel) 2020
4

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.
Ranjit Manchanda, Sari Lieberman, Faiza Gaba, Amnon Lahad, Ephrat Levy-Lahad. Annu Rev Genomics Hum Genet 2020
9

Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer.
Barbara Wappenschmidt, Jan Hauke, Ulrike Faust, Dieter Niederacher, Lisa Wiesmüller, Gunnar Schmidt, Evi Groß, Andrea Gehrig, Christian Sutter, Juliane Ramser,[...]. Geburtshilfe Frauenheilkd 2020
2